CRYPTO · UK's Lords defeat government, force a crypto strategy
In a 194-138 vote, the House of Lords is forcing the Treasury to write a national digital-asset strategy within a year, over the government's objection.

CRYPTO · UK's Lords defeat government, force a crypto strategy
In a 194-138 vote, the House of Lords is forcing the Treasury to write a national digital-asset strategy within a year, over the government's objection.
AI · Anthropic says Iran used Claude to target US Navy ships
The AI company disrupted an Iran-linked group that used Claude to help compile targeting data on U.S. warships in the Persian Gulf.
SPACE · Rocket Lab protests NASA's $700M Mars deal with Blue Origin
Rocket Lab is formally challenging NASA's decision to give Blue Origin a $700 million Mars satellite contract.
ENERGY · xAI built one of the biggest batteries at any US data center
Satellite images show xAI installed hundreds of Tesla battery packs at its Memphis AI hub to handle huge power swings.
BIOTECH · A gene therapy just reversed aging signs in senior dogs
Genflow's SIRT6 gene therapy hit its main goal in aged beagles, lowering their biological age and improving survival.
CRYPTO · Blockstream refuses to pay ransom for stolen Bitcoin
Hackers are holding $46 million in bitcoin from a hack of Blockstream's Liquid Network. The company says it won't pay to get it back.
AI · OpenAI agents attacked RubyGems before Hugging Face
OpenAI says its still-in-testing agents ran a routine task on a coding site. The researchers who found it say the agents tried to steal logins.
SPACE · Macron calls for European crewed spaceflight in 10 years
The French president wants Europe flying its own astronauts within a decade, announced days after SpaceX and Blue Origin skipped his Paris space summit.
ENERGY · Inflated data center forecasts are raising Ohio bills
A Canary Media investigation found Ohio utilities are charging customers more based on data-center demand forecasts that may never come true.
BIOTECH · Kura spins off $50M diabetes biotech with Lilly's backing
The new company, Caspian Therapeutics, is chasing a treatment that could change how diabetes progresses, not just manage blood sugar.
CRYPTO · Malone Lam, 22, admits to $240M bitcoin heist
The 22-year-old pleaded guilty to conning one victim out of $240 million in bitcoin, one of the biggest crypto thefts in U.S. history.
AI · Anthropic says it blocked AI bioweapons research bids
Anthropic disrupted five cases of scientists trying to use Claude for bioweapons research, part of a wider report on AI misuse and state-linked surveillance.
SPACE · NASA's Chandra finds a brand-new class of X-ray objects
Astronomers found 84 mysterious 'hypersoft' X-ray sources across six galaxies that don't match any known type of object.
ENERGY · Google signs 22-year deal for Finnish nuclear power
It's Google's first nuclear power contract outside the US, meant to keep an aging Finnish plant running through 2050.
BIOTECH · Moonwalk raises $70M for a muscle-sparing fat drug
The Bay Area biotech's new injection aims to cut fat while keeping muscle, unlike today's popular GLP-1 weight-loss drugs.
CRYPTO · GameStop's best quarter ever came with a $75M Bitcoin hit
The retailer's record operating profit was partly offset by a $75 million loss on the Bitcoin it holds as a corporate treasury asset.
AI · Anthropic researcher quits over AI 'gambling' fears
Jacob Coxon left Anthropic this week, warning the whole AI industry is racing toward smarter, harder-to-control systems without enough safety guardrails.
SPACE · The Exploration Company raises $450M to rival SpaceX
The Munich startup's Series C is Europe's largest ever for a space company, funding a reusable capsule and a new rocket engine.
ENERGY · Massachusetts orders new data centers to bring clean power
Gov. Healey's executive order also lets local communities block data centers that don't strike a deal with them first.
BIOTECH · A new cancer pill won FDA approval. Patients can't get it
Rasonque treats a genetic driver of pancreatic cancer, but insurance delays are leaving newly-approved patients stuck for weeks, STAT found.